Welcome to our dedicated page for Fonar SEC filings (Ticker: FONR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FONAR Corporation filings document the public-company record for its MRI scanner and diagnostic imaging management business. Proxy materials cover board elections, advisory executive-compensation votes and auditor ratification, while Form 8-K reports disclose operating results, governance changes and other material events.
The filing record also includes capital-structure and material-agreement disclosures, shareholder voting matters and notices related to periodic reporting, including Form 12b-25 notifications for delayed quarterly reports. These documents frame FONAR's reporting obligations around financial results, governance, shareholder voting and corporate events.
FONAR Corporation reported Q1 FY2026 results for the three months ended September 30, 2025. Total revenue was $26.043 million, up 4.3% year over year, while operating income fell to $3.194 million from $4.606 million as costs rose faster than sales. Net income attributable to FONAR was $2.264 million, and net income available to common stockholders was $2.120 million, with basic and diluted EPS of $0.34.
Growth was led by management and other fees and higher product and service activity. The company performed 55,106 scans, up from 53,054. Expenses increased 12.2% to $22.849 million, reflecting a prior-year $600,000 over‑accrual benefit, costs tied to the proposed going‑private transaction, IT and cybersecurity spending, and a $100,000 credit loss reserve increase primarily related to American Transit Insurance Company.
Cash and equivalents were $54.276 million (down from $56.334 million at June 30, 2025). Operating cash flow was $1.689 million; investing used $2.367 million and financing used $1.380 million. A CEO/COO‑led group submitted a non‑binding proposal on July 7, 2025 to acquire all outstanding equity; a Special Committee is negotiating, and no definitive agreements have been executed. The stock repurchase plan remains suspended, with $2.928 million authorization remaining.
FONAR Corporation (Form 10-K) reported consolidated financial and operational details for fiscal 2025, highlighting its continued majority ownership of Health Diagnostics Management (HDM) and material credit reserving. The company sold a non-controlling interest for $132,000, leaving a direct HDM ownership of 70.63% and investors with 29.37%. Management tested internal controls over patient fee revenue, CECL estimates and IT general controls for its billing systems.
The filing discloses an allowance for credit losses of $4,366,000, recorded valuation allowances against state net operating losses, and detailed share activity including repurchases: the company repurchased 114,588 shares at a cost of $1,806,646 and cancelled 124,829 shares valued at $1,963,385. The company derives a large portion of revenues from no-fault and personal injury protection (about 67% of net revenues).
FONAR Corporation (Form 10-K) reported consolidated financial and operational details for fiscal 2025, highlighting its continued majority ownership of Health Diagnostics Management (HDM) and material credit reserving. The company sold a non-controlling interest for $132,000, leaving a direct HDM ownership of 70.63% and investors with 29.37%. Management tested internal controls over patient fee revenue, CECL estimates and IT general controls for its billing systems.
The filing discloses an allowance for credit losses of $4,366,000, recorded valuation allowances against state net operating losses, and detailed share activity including repurchases: the company repurchased 114,588 shares at a cost of $1,806,646 and cancelled 124,829 shares valued at $1,963,385. The company derives a large portion of revenues from no-fault and personal injury protection (about 67% of net revenues).
Money Concepts Capital Corp reported owning 462,760 shares of FONAR Corp common stock, representing 7.5% of the class. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
The filer reports sole dispositive power over 462,760 shares and no voting power (sole or shared). The Schedule 13G/A identifies the filers principal office in Palm Beach Gardens, Florida, and lists the issuers principal executive office in Melville, New York.
Renaissance Technologies reports a 5.09% stake in Fonar Corporation, representing 315,516 shares held with sole voting and dispositive power. That level of ownership makes Renaissance a material minority investor but the filing states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control.
Two related entities—Renaissance Technologies LLC (an investment adviser) and Renaissance Technologies Holdings Corporation (a holding company)—report identical ownership and note that certain funds they manage have the right to receive dividends or sale proceeds from these shares.
Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 544,036 shares of Fonar Corp ordinary stock, representing 8.8% of the class. The filer indicates sole voting power and sole dispositive power over all reported shares. The statement is filed as a Schedule 13G amendment and the filer certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing lists the reporting person as an investment adviser (Type IA) and notes no shared power or group affiliation.
Fonar Corporation (Nasdaq: FONR) filed a Form 8-K on June 23, 2025 to disclose a governance change under Item 5.02. Claudette J.V. Chan, a member of the Board of Directors and the Company’s Secretary, notified the Company of her intention to retire effective June 19, 2025. The filing explicitly states that Ms. Chan cited no disagreements with the Company’s operations, policies, or practices. No successor appointments, financial updates, or additional corporate actions were included in the report.
President & CEO Timothy R. Damadian signed the filing, confirming compliance with SEC disclosure requirements. Aside from the routine leadership transition, the 8-K contains no material financial data or strategic changes.